Greater Cannabis Company Inc (GCAN) Predicción del precio de las acciones

The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.